The Centers for Disease Control and Prevention have introduced the nation's first surveillance system to track adverse events in patients who receive blood transfusions, and the Atlanta-based agency is encouraging healthcare facilities to enroll in the new network.
Part of the CDC's National Healthcare Safety Network, the new Hemovigilance Module is an Internet-based surveillance system that allows healthcare-associated infection data to be tracked and analyzed so the CDC and healthcare facilities can maximize prevention efforts. The CDC developed the system with AABB, an international association that represents people and institutions involved in activities related to transfusion and cellular therapies, including transplantation medicine.
“Healthcare facilities that join the Hemovigilance Module will now have a yardstick by which to measure their current safety initiatives and their future efforts,” said Dan Pollock, chief of the branch that leads the agency's National Healthcare Safety Network, in a news release. “Through this system, healthcare facilities can also see how their performance stacks up to similar facilities nationwide, with a goal of designing the best processes to protect patients' health and reduce healthcare costs.”
The CDC said it will provide the module at no cost to healthcare facilities, and will also provide training and ongoing user support at no charge to hospitals.